Results 191 to 200 of about 42,363 (276)

Daunorubicin‐45 Vs. Daunorubicin‐60 for Induction in Intermediate‐Age Patients of AML: Results From a Randomized Trial

open access: yesCancer Science, Volume 117, Issue 6, Page 1690-1700, June 2026.
Daunorubicin dose escalation from 45 to 60 mg/m2 provides no clinical benefit for AML patients aged 55–65. A dose of 45 mg/m2 should remain the preferred regimen for this population. ABSTRACT Daunorubicin dose optimization remains crucial for AML treatment.
Chunlin Zhou   +15 more
wiley   +1 more source

Predictive Factors for Relapse in Still's Disease: A Retrospective Cohort Study of Clinical and Laboratory Biomarkers

open access: yesClinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT This retrospective cohort study aimed to identify clinical and laboratory predictors of relapse in patients with Still's disease. A total of 94 patients diagnosed by Yamaguchi or Fautrel criteria across two rheumatology centers between 2012 and 2024 were evaluated, of whom 87 were eligible for analysis.
İbrahim Yahya Çakır   +12 more
wiley   +1 more source

Severe Hypoalbuminemia in a Cow

open access: yesJournal of the Japan Veterinary Medical Association, 1997
SATO, Jun   +5 more
openaire   +2 more sources

Diagnosing Systemic Mastocytosis: State of the Art

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 3, Page 551-560, June 2026.
ABSTRACT With the advent of effective multikinase and selective tyrosine kinase inhibitors in systemic mastocytosis, diagnosing this rare disease has been critical to improving patient morbidity and mortality. This state‐of‐the‐art review interprets the international diagnostic criteria, including differences between the WHO 5th edition classification ...
Anton Rets, Tracy I. George
wiley   +1 more source

Clinical Value of Early Serum Albumin in Predicting Mortality Among Patients With Acute Pancreatitis: A Meta-Analysis. [PDF]

open access: yesCureus
Helali MA   +15 more
europepmc   +1 more source

Feet in Peril: Assessment of Feet in Patients Undergoing Haemodialysis

open access: yesJournal of Renal Care, Volume 52, Issue 2, June 2026.
ABSTRACT Background Foot problems are common in haemodialysis patients, making treatment and disease management difficult due to their serious complications and creating a significant financial burden on healthcare expenses. Objective In this study, we assessed the foot problems in haemodialysis patients.
Aysun Ünal   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy